A 12-year retrospective clinical study of patients who received peptide receptor radionuclide therapy for malignant neuroendocrine tumors demonstrates the long-term effectiveness of this treatment, which also allows patients to maintain a high quality of life.
from Latest Science News -- ScienceDaily http://bit.ly/2UTsWKl
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment